| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 08/26/2008 | US7417156 water-soluble carboxylic acid dimers that are thermally stable and stable toward hydrolysis, less toxicity; plasmodium protozoan parasites; human malaria and Plasmodium falciparum; leukemia, lung, colon, central nervous system, ovarian, renal, prostate, and breast cancer, melanoma |
| 08/26/2008 | US7417070 Compounds and methods for delivery of prostacyclin analogs |
| 08/26/2008 | US7417069 Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 08/26/2008 | US7417034 Pharmaceutically active uridine esters |
| 08/26/2008 | US7416743 a mixture of Commiphora mukul, Boswellia serrata, Semecarpus anacardium Strychnox nux vomica, Terminalia arjuna and Shankha Bhasma |
| 08/26/2008 | US7416734 Vaccines for Mycoplasma bovis and methods of use |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/26/2008 | CA2361614C Compositions for treating inflammatory response |
| 08/26/2008 | CA2312021C Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis |
| 08/21/2008 | US20080200426 Use of Chondroitin Sulphate E (Cs-E) for the Treatment of Diseases or Conditions Related to Collagen Fibril Formation |
| 08/21/2008 | US20080199931 Expression vector comprising estrogen signaling protein (IEBP) for use as tool in diagnosis, prevention and treatment of cell proliferative abd bone disorders |
| 08/21/2008 | US20080199459 Mitotic Kinesin Inhibitors |
| 08/20/2008 | EP1958956A2 Peptidomimetic protease inhibitors |
| 08/20/2008 | EP1957155A1 Face mask |
| 08/20/2008 | EP1651956A4 Melks as modifiers of the rac pathway and methods of use |
| 08/20/2008 | EP1633317A4 Synthetic chemokine receptor ligands and methods of use thereof |
| 08/20/2008 | EP1587821B1 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 08/20/2008 | EP1255547B1 Controlled-release compositions containing opioid agonist and antagonist |
| 08/20/2008 | EP1249233B1 Npyy5 antagonists |
| 08/20/2008 | EP1047455B1 Para-hydrogen labelled agents and their use in non-proton magnetic resonance imaging |
| 08/20/2008 | CN101247768A System and method for the photodynamic treatment of burns, wounds, and related skin disorders |
| 08/20/2008 | CN101245058A Inhibitors of aspartyl protease |
| 08/20/2008 | CN101245043A Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 08/20/2008 | CN100412084C Thermally stable crystalline epirubicin hydrochloride and method of making the same |
| 08/20/2008 | CN100411684C Use of FVIIa or tissue factor antagonist for regulating gene expression and cell migration or chemotaxis |
| 08/19/2008 | US7414067 Ophthalmic compositions for treating ocular hypertension |
| 08/19/2008 | US7414056 Cytokine inflammatory response suppressors; mitogen activated protein 38 kinases |
| 08/19/2008 | US7414055 Inhibitors of Akt activity |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/14/2008 | WO2004064783A3 Eosinophil-derived neurotoxin as a marker for ovarian cancer |
| 08/14/2008 | US20080194682 administering inhibitors of endopeptidase such as thiorphan or candoxatril, to effect bone elongation; achondroplasia |
| 08/14/2008 | US20080194625 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 08/14/2008 | US20080194568 Pyridomorphinans, Pyridazinomorphinans and Use Thereof |
| 08/14/2008 | US20080194472 Use of Fgf-18 Protein, Target Proteins and Their Respective Encoding Nucleotide Sequences to Induce Cartilage Formation |
| 08/14/2008 | US20080194019 Administering metformin and/or phenformin; for treatment of diabetes and cancer; drug screening |
| 08/14/2008 | US20080193466 Administering human antibody, or an antigen-binding fragment thereof, to subject, wherein antibody dissociates from human TNF alpha with a Kd of 1x10-8 M or less and a Koff rate constant of 1x10-3 s-1 or or less, and neutralizes human TNF alpha cytotoxicity with an IC50 of 1x10-7 M or less in L929 assay |
| 08/14/2008 | US20080193454 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 08/14/2008 | US20080193441 Homogeneous Preparations of Chimeric Protein |
| 08/14/2008 | US20080193389 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms |
| 08/13/2008 | EP1956004A1 Quinoline derivatives and their use as 5-HT6 ligands |
| 08/13/2008 | EP1603532B1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 08/13/2008 | EP1539714B1 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 08/13/2008 | EP0936913B1 Oral pharmaceutical preparation containing ibandronat |
| 08/13/2008 | EP0647137B1 Glycine receptor antagonists and the use thereof |
| 08/13/2008 | CN101242850A Composition, function and use of xanthoceras sorbifolia extract and compound isolated from same, method for preparing same |
| 08/13/2008 | CN101239090A Pharmaceutical compositions having appetite suppressant activity |
| 08/13/2008 | CN101239089A Pharmaceutical compositions having appetite suppressant activity |
| 08/13/2008 | CN101238895A Nutrition replenisher for JUCARA and ACAI fruit group |
| 08/13/2008 | CN100410245C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/12/2008 | US7411073 cyclopent[f]pyrazole derivatives; antiinflammatory agent; autoimmune diseases; side effect reduction, advantages over steroidal glucocorticoid ligands with respect to undesireable side-effects, efficacy, toxicity or metabolism |
| 08/12/2008 | US7411070 Form of S-omeprazole |
| 08/12/2008 | US7411044 Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing |
| 08/12/2008 | US7410969 Antitumoral analogs of ET-743 |
| 08/12/2008 | US7410801 Obtaining recombinant lambdoid bacteriophage with high density display of functional peptides and proteins on surface via viral propagation in microorganismal host |
| 08/12/2008 | US7410759 Compositions and methods for diagnosing and treating mood disorders |
| 08/12/2008 | CA2315721C Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 08/12/2008 | CA2303370C Dentifrices of enhanced efficacy containing fluoride and casein glycomacropeptide |
| 08/12/2008 | CA2257810C Skin wash composition comprising an .alpha.-hydroxy acid or other acid and a detergent base |
| 08/07/2008 | US20080188497 Combination regime; preventing stroke or reducing the risk of stroke or secondary stroke |
| 08/07/2008 | US20080187993 Coupling antisense angents to reverse TAT polypeptide to enhance uptake into activated macrophage and/or lymphocytes; prevention and treatment of human immunodeficiency viral infection |
| 08/07/2008 | US20080187978 Anti-inflammatory medicaments |
| 08/07/2008 | US20080187573 Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase b inhibitor component |
| 08/07/2008 | US20080187540 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 08/06/2008 | EP1953142A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives |
| 08/06/2008 | EP1952792A1 Methods of using FET labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same |
| 08/06/2008 | EP1951790A2 Initiators and crosslinkable polymeric materials |
| 08/06/2008 | EP1592388A4 Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin |
| 08/06/2008 | CN101238370A Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408564C Pyrazole derivatives for treating HIV |
| 08/05/2008 | US7407974 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407972 e.g. 4,5-Dihydro-pyrazole-1,5-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 5-[(3-fluoro-2'-methanesulfonyl-biphenyl-4-yl)-amide]; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease |
| 08/05/2008 | US7407956 Benzamide inhibitors of the P2X7 receptor |
| 08/05/2008 | US7407941 N-desmethyl-N-substituted-11-deoxyerythromycin compounds |
| 08/05/2008 | US7407932 Exendin agonist composed of a peptide in which at least one amino acid residue is acylated with a dicarboxylic acid; the amino acid residues are an internal lysine residue, an N-terminal amino acid residue, and/or a C-terminal amino acid residue; treatment of glucagonoma |
| 08/05/2008 | US7407802 Plasmid comprising nucleotide sequences coding vaccine specific to newcastle disease virus hemagglutinin-neuraminidase (HN) for use in prevention and treatment of viral diseases in plants |
| 08/05/2008 | US7407792 Compositions, organisms and methodologies employing a novel human kinase |
| 08/05/2008 | US7407767 Treating dilated cardiomyopathy by removing anti-cardiac troponin autoantibody from patient's blood |
| 08/05/2008 | US7407653 Treatment of IgA1 deposition diseases |
| 07/31/2008 | US20080182792 Diminishing presence of protein aggregates in an environment susceptible to formation of protein aggregate by introducing into environment a compound having two domains, a first domain that binds to protein aggregation having two monomers, and a second domain binding to diminishing protein |
| 07/31/2008 | US20080181914 an inactivated, disrupted influenza virus preparation of a hemagglutinin antigen stabilised by alpha-tocopherol succinate in the absence or at low levels of thiomersal; hemagglutinin detectable by a single radial immunoassay (SRID); mercury-free preservative; administering by any route |
| 07/31/2008 | US20080181908 Genes and proteins, and their use |
| 07/30/2008 | EP1949936A2 Controlled release composition and method of producing the same |
| 07/30/2008 | EP1601652B1 Pyridinium salts, compounds and methods of use |
| 07/30/2008 | EP1575553A4 In vivo production of cyclic peptides for inhibiting protein-protein interaction |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406451C Process for preparing prostaglandin derivatives and starting materials for the same |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406008C Pharmaceutical composition comprising lumiracoxib |
| 07/29/2008 | US7405198 Glycopegylated erythropoietin |
| 07/29/2008 | US7404950 Induced activation in dendritic cell |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2333656C A novel vla-4 inhibitor: omepupa-v |
| 07/29/2008 | CA2324077C Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 07/29/2008 | CA2261835C Long-acting drugs and pharmaceutical compositions comprising them |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/24/2008 | WO2004082598A3 Relaxin3-gpcr135 complexes and their production and use |
| 07/24/2008 | US20080176887 Method for Decreasing Nicotine and Other Substance Use in Humans |
| 07/24/2008 | US20080176880 Activity against strains having acquired resistance nonnucleoside reverse transcriptase inhibitors; human alpha1 acid glycoprotein nonbinding; such as 4-[[(5-bromo-4,6-dichloro)-2-pyrimidinyl]amino]-benzonitrile |